Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.
about
Revisiting the Basic Symptom Concept: Toward Translating Risk Symptoms for Psychosis into Neurobiological TargetsTranslating the MAM model of psychosis to humansAn Overview of the Association between Schizotypy and Dopamine.How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of PsychosisDietary supplementation with n-3 fatty acids from weaning limits brain biochemistry and behavioural changes elicited by prenatal exposure to maternal inflammation in the mouse model.Corticolimbic dysfunction during facial and prosodic emotional recognition in first-episode psychosis patients and individuals at ultra-high risk.Molecular substrates of schizophrenia: homeostatic signaling to connectivityOlfaction in the psychosis prodrome: electrophysiological and behavioral measures of odor detection.Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans.Structural Network Disorganization in Subjects at Clinical High Risk for Psychosis.An Integrative Perspective on the Role of Dopamine in SchizophreniaSchizophrenia: an integrated sociodevelopmental-cognitive model.Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission.Pathway-Specific Dopamine Abnormalities in Schizophrenia.The 4th Schizophrenia International Research Society Conference, 5-9 April 2014, Florence, Italy: a summary of topics and trends.Striatal D(2/3) Binding Potential Values in Drug-Naïve First-Episode Schizophrenia Patients Correlate With Treatment Outcome.Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis.Examining associations between psychosis risk, social anhedonia, and performance of striatum-related behavioral tasks.The early identification of psychosis: can lessons be learnt from cardiac stress testing?Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean CohortsGlutamate and dopamine in schizophrenia: an update for the 21st centuryNeurophysiological evidence of impaired self-monitoring in schizotypal personality disorder and its reversal by dopaminergic antagonism.A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia.Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging studyMolecular imaging as a guide for the treatment of central nervous system disordersAdversity in childhood linked to elevated striatal dopamine function in adulthood.Longitudinal alterations in motivational salience processing in ultra-high-risk subjects for psychosis.The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review.A synthesis of evidence on inhibitory control and auditory hallucinations based on the Research Domain Criteria (RDoC) framework.Prediction and prevention of the first psychotic episode: new directions and opportunities.Neurodegenerative aspects in vulnerability to schizophrenia spectrum disorders.Presynaptic dopaminergic function: implications for understanding treatment response in psychosis.The neurobiology and treatment of first-episode schizophrenia.New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways.Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features.Striatal dopamine, reward, and decision making in schizophreniaAdolescent Stress as a Driving Factor for Schizophrenia Development-A Basic Science Perspective.Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression.Common Variation in the DOPA Decarboxylase (DDC) Gene and Human Striatal DDC Activity In Vivo.Early Detection of Psychosis: Recent Updates from Clinical High-Risk Research.
P2860
Q26767499-977C0D49-DC82-4461-B6A4-15AD90E01709Q26860217-901211B8-09FD-4E09-9137-F1539191AA57Q26991569-53F49F25-A978-4142-BF56-371E65C54AA6Q28087255-F352924B-4A1C-4101-B528-1ABAB846A3C5Q30372082-2AB0D7AE-1E0A-42B8-9DA9-3553D572FEB2Q30372428-46C0F8CD-9F99-47F0-B222-C8F726D3B23FQ30383611-80DA2075-8735-42E8-8495-9466B01C63FDQ30427083-F65A7631-8C83-4DA8-ACB0-537CB0B7FB6FQ33707670-C3DB96BF-CE30-4258-8C5F-7115E061AEFDQ33777660-F41976EC-1728-4258-8D53-E2A641572BE9Q33839379-4FCE0CB3-A797-4C91-AB18-CB58C606FC9AQ34023115-47B48E8F-14A9-440A-84E7-6D7D9C767CFDQ34410670-0A79104E-D937-4B72-8BF0-FC5012F5C1F0Q34527656-DF73A608-AB3C-4A5A-8A3A-3BF3BB76B294Q35382798-016F8DC5-5312-4F9F-B0C5-1EC2B291F748Q35950793-5C73E96D-F7A7-4B83-8CFB-F1C742161D0BQ35950814-B9EF83CC-ABF1-4E4A-9186-A6BE513C1A42Q36070250-83D2D51C-1286-40B3-BCD8-35B26D24EFA3Q36437209-11223982-08BD-4D22-BB98-26A2AB7E3011Q36817270-E0EA5CEA-CA8A-4894-94B2-57BAF17C277BQ36992322-C98681F2-F615-480D-9B64-ACA3F6132521Q37009643-3CEAB2C8-4CF2-4B6A-9412-8AE6DF4DEA82Q37212874-421B3A43-3468-417A-968E-EE024F8265CFQ37256211-D0C9150E-8611-40EF-BB0B-CEECD0F19AC2Q37262953-9B4AF1CD-4845-41F1-8EB9-017A429363A4Q37489007-96679CFD-1BDF-4271-A237-97B4DA5BD7C0Q37563725-C4ED2064-2810-4E14-A7F5-820B1BA674EFQ37633236-E95C91A3-C0ED-4E3B-B893-18EEF9E7FC46Q37678875-4CDED0F6-F0E0-4E43-A652-72DBE55433D4Q37682795-A8B9519B-3817-4E39-A0A2-CA7DB5839F56Q38209971-D723C45A-C16E-4932-A3AB-EBDCD742386CQ38219577-6FC8DF34-AE41-4444-8EEE-45344157E616Q38232366-532A46FE-7C71-4023-B238-AD5DDFD89914Q38233857-6BF9D131-B877-4BE0-A66D-6ACDA67EBC7DQ38650161-A4FD76F1-D075-4E7C-9137-754C664D2CC2Q38805970-732C007D-86B5-41F6-96BC-118153587E44Q38832247-2BD8EB07-839D-4351-8C01-5224FF4E3E24Q38852249-E9E0A111-6C3A-4713-8677-7984B86C5FDAQ38902250-0B3F99C3-87AC-4566-94EE-1585FEEBC738Q38929213-223A5D60-DF75-4E06-89F1-F726AC63D0FD
P2860
Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Presynaptic striatal dopamine ...... : findings in a second cohort.
@en
Presynaptic striatal dopamine ...... : findings in a second cohort.
@nl
type
label
Presynaptic striatal dopamine ...... : findings in a second cohort.
@en
Presynaptic striatal dopamine ...... : findings in a second cohort.
@nl
prefLabel
Presynaptic striatal dopamine ...... : findings in a second cohort.
@en
Presynaptic striatal dopamine ...... : findings in a second cohort.
@nl
P2093
P50
P921
P1476
Presynaptic striatal dopamine ...... s: findings in a second cohort
@en
P2093
Alice Egerton
Christopher A Chaddock
Toby T Winton-Brown
P304
P356
10.1016/J.BIOPSYCH.2012.11.017
P407
P577
2013-01-08T00:00:00Z